Plasma Services Group

Plasma Services Group (PSG) is a specialized company founded in 2004 that supports the global in vitro diagnostics (IVD) and life sciences industries. PSG provides high-quality, rare biological materials essential for research, development, and manufacturing, with a strong focus on rare diseases. The company is recognized for its expertise in the specialty antibody collection process, particularly for medical diagnostic and pharmaceutical applications. PSG offers a range of services, including the collection, screening, and supply of biological materials like sera and plasma. They provide bulk disease state plasma collection tailored to customer needs and offer assay-specific data to support research and manufacturing. PSG also has a national donor recruitment program for global sample collection and provides quality assurance and regulatory affairs consulting. Operating from a state-of-the-art FDA-registered, ISO-certified facility in Moorestown, New Jersey, PSG emphasizes quality, integrity, and personalized service to meet the needs of IVD manufacturers, life science researchers, and pharmaceutical companies. In 2023, PSG was acquired by Fujirebio Holdings, Inc., enhancing its position as a global supplier in the industry.

• Employees 14
• Founded 2004
• Annual Revenue $4037000